相似文献
1
Rifampin-resistant meningococcal disease.
Emerg Infect Dis. 2005 Jun;11(6):977-9. doi: 10.3201/eid1106.050143.
2
Molecular characterization of resistance to rifampicin in clinical isolates of Neisseria meningitidis.
Clin Microbiol Infect. 2009 Dec;15(12):1178-81. doi: 10.1111/j.1469-0691.2009.02783.x. Epub 2009 May 16.
3
Rifampin-resistant Neisseria meningitidis.
Emerg Infect Dis. 2006 May;12(5):859-60. doi: 10.3201/eid1205.051296.
4
Emergence of ciprofloxacin-resistant Neisseria meningitidis in North America.
N Engl J Med. 2009 Feb 26;360(9):886-92. doi: 10.1056/NEJMoa0806414.
5
Surveillance of antimicrobial resistance in Neisseria meningitidis strains isolated from invasive cases in Brazil from 2009 to 2016.
J Med Microbiol. 2018 Jun;67(6):750-756. doi: 10.1099/jmm.0.000743. Epub 2018 May 2.
6
Emergence of fluoroquinolone-resistant Neisseria meningitidis--Minnesota and North Dakota, 2007-2008.
MMWR Morb Mortal Wkly Rep. 2008 Feb 22;57(7):173-5.
7
Invasive meningococcal disease due to ciprofloxacin-resistant Neisseria meningitidis sequence type 4821: The first case in Japan.
J Infect Chemother. 2018 Apr;24(4):305-308. doi: 10.1016/j.jiac.2017.11.001. Epub 2017 Dec 7.
8
Management of a rifampicin-resistant meningococcal infection in a teenager.
Infection. 2013 Jun;41(3):705-8. doi: 10.1007/s15010-013-0418-y. Epub 2013 Feb 14.
9
Meningococcemia in identical twins: changes in serum susceptibility after rifampin chemoprophylaxis.
J Infect Dis. 1988 May;157(5):1064-8. doi: 10.1093/infdis/157.5.1064.
10
Have South Australian isolates of Neisseria meningitidis become less susceptible to penicillin, rifampicin and other drugs? A study of strains isolated over three decades, 1971-1999.
Pathology. 2004 Apr;36(2):160-5. doi: 10.1080/00313020410001672000.
引用本文的文献
1
Genomic characterization of invasive in Spain (2011/12-2022/23): expansion of clonal complex 213 and the potential threat to 4CMenB vaccine strain coverage.
Emerg Microbes Infect. 2025 Dec;14(1):2482696. doi: 10.1080/22221751.2025.2482696. Epub 2025 Mar 27.
2
Progression of antibiotic resistance in .
Clin Microbiol Rev. 2025 Mar 13;38(1):e0021524. doi: 10.1128/cmr.00215-24. Epub 2025 Jan 31.
3
Meningococcal Antibiotic Resistance: Molecular Characterization of Isolates from Patients with Invasive Meningococcal Disease (IMD) in Greece.
Antibiotics (Basel). 2023 Jun 30;12(7):1136. doi: 10.3390/antibiotics12071136.
4
Biochemical and structural characterization of meningococcal methylenetetrahydrofolate reductase.
Protein Sci. 2023 Jun;32(6):e4654. doi: 10.1002/pro.4654.
5
Susceptibilities of invasive strains to agents used for prophylaxis and to penicillin G.
J Assoc Med Microbiol Infect Dis Can. 2021 Dec 3;6(4):307-312. doi: 10.3138/jammi-2020-0034. eCollection 2021 Dec.
6
Antibiotic resistance among invasive Neisseria meningitidis isolates in England, Wales and Northern Ireland (2010/11 to 2018/19).
PLoS One. 2021 Nov 29;16(11):e0260677. doi: 10.1371/journal.pone.0260677. eCollection 2021.
7
Population-Based Surveillance of Neisseria meningitidis Antimicrobial Resistance in the United States.
Open Forum Infect Dis. 2015 Aug 13;2(3):ofv117. doi: 10.1093/ofid/ofv117. eCollection 2015 Sep.
8
Management of a rifampicin-resistant meningococcal infection in a teenager.
Infection. 2013 Jun;41(3):705-8. doi: 10.1007/s15010-013-0418-y. Epub 2013 Feb 14.
9
Neisseria meningitidis rifampicin resistant strains: analysis of protein differentially expressed.
BMC Microbiol. 2010 Sep 24;10:246. doi: 10.1186/1471-2180-10-246.
10
Antibiotic susceptibility and characteristics of Neisseria meningitidis isolates from the African meningitis belt, 2000 to 2006: phenotypic and genotypic perspectives.
Antimicrob Agents Chemother. 2009 Apr;53(4):1561-6. doi: 10.1128/AAC.00994-08. Epub 2009 Feb 2.
本文引用的文献
1
Neisseria meningitidis showing decreased susceptibility to ciprofloxacin: first report in Spain.
J Antimicrob Chemother. 2004 Feb;53(2):409. doi: 10.1093/jac/dkh075. Epub 2004 Jan 16.
2
Rifampicin-resistant meningococci causing invasive disease: detection of point mutations in the rpoB gene and molecular characterization of the strains.
J Antimicrob Chemother. 2001 Feb;47(2):219-22. doi: 10.1093/jac/47.2.219.
3
Evaluation of pulsed-field gel electrophoresis in epidemiological investigations of meningococcal disease outbreaks caused by Neisseria meningitidis serogroup C.
J Clin Microbiol. 2001 Jan;39(1):75-85. doi: 10.1128/JCM.39.1.75-85.2001.
4
An invasive isolate of Neisseria meningitidis showing decreased susceptibility to quinolones.
Antimicrob Agents Chemother. 2000 Apr;44(4):1116. doi: 10.1128/AAC.44.4.1116-1116.2000.
5
Meningococcal disease in siblings caused by rifampicin sensitive and rifampicin resistant strains.
Commun Dis Public Health. 1999 Sep;2(3):215-6.
6
Rifampicin resistance in Neisseria meningitidis: evidence from a study of sibling strains, description of new mutations and notes on population genetics.
J Antimicrob Chemother. 1997 Jun;39(6):747-55. doi: 10.1093/jac/39.6.747.
7
Evaluation of the use of mass chemoprophylaxis during a school outbreak of enzyme type 5 serogroup B meningococcal disease.
Pediatr Infect Dis J. 1996 Nov;15(11):992-8. doi: 10.1097/00006454-199611000-00012.
8
Rifampicin-resistant meningococci causing invasive disease and failure of chemoprophylaxis.
Lancet. 1993 May 1;341(8853):1152-3. doi: 10.1016/0140-6736(93)93171-v.
9
Molecular characterization of rifampin-resistant Neisseria meningitidis.
Antimicrob Agents Chemother. 1994 Jun;38(6):1256-61. doi: 10.1128/AAC.38.6.1256.
10
First recorded outbreaks of meningococcal disease in the Israel Defence Force: three clusters due to serogroup C and the emergence of resistance to rifampicin.
Infection. 1994 Mar-Apr;22(2):69-71. doi: 10.1007/BF01739006.
Zotero 插件